Pricing of Oversubscribed USD 110 Million Financing of Oculis Holding AG
Oculis Holding AG (Nasdaq: OCS; XICE: OCS), a global biopharmaceutical company focused on breakthrough innovations to address significant unmet medical needs in ophthalmology and neuro-ophthalmology, announced the pricing of...
RetinAI acquired by EssilorLuxottica
EssilorLuxottica, a global leader in vision care and eyewear, has acquired Ikerian AG, a health technology company operating under the RetinAI brand, specializing in AI and data management in eyecare.
VISCHER advises Family Trust on the sale of novia Group to Swedish Bufab Group
VISCHER advises Family Trust on the sale of novia Group, a provider of global sourcing solu-tions and engineering services operating across Germany, Switzerland, China, and Vietnam to the Swedish Bufab Group.
VISCHER advised Blue Owl in connection with the USD 500 m financing to Madrigal Pharmaceuticals
VISCHER advised Blue Owl on all Swiss legal aspects of the financing transaction, including an up to USD 500 million term loan facility for Madrigal Pharmaceuticals.
Proteomedix AG licenses manufacturing IP to Immunovia AB
VISCHER advised Proteomedix AG, a Swiss biotech subsidiary of Onconetix, Inc., on a licensing agreement with Immunovia AB, a Swedish pancreatic cancer diagnostics company.
Medartis acquires remaining 53% of KeriMedical
Medartis (SIX: MED), an orthopedic company based in Basel specializing in head and extremity surgery, has acquired the remaining 53% of Geneva-based KeriMedical SA and is now the sole owner of the company.
AutoScout24 integrates the C2B business from CARAUKTION
VISCHER advised CARAUKTION on the takeover of the C2B business division, including the C2B auction platform, by AutoScout24.
Schivo acquires Mecaplast SA
VISCHER advised Schivo on the acquisition of Mecaplast SA.
VISCHER advised LOOMIS AB in its acquisition of Kipfer Logistik GmbH
VISCHER advised LOOMIS AB in its acquisition of Kipfer Logistik GmbH, a Switzerland-based logistics company specializing in temperature-controlled transport and storage in the pharmaceutical sector.
Claraspital Basel is being acquired by University Hospital Basel
The University Hospital Basel (USB), one of Switzerland's leading university hospitals, is acquiring St. Claraspital AG, a leading, systemically important hospital in north-western Switzerland, from St. Clara AG and the Ingenbohl Monastery.